Skip to main content

Advertisement

Table 2 Count of activities mentioned in pharmacovigilance-related coded excerpts, stratified by type (N = 288)

From: Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries

Pharmacovigilance area of interest
Activity type Adverse events Counterfeit drugs Drug quality assurance PV NOS N/A Total
 Behaviour change communication   6 (85.7) 1 (14.3)    7 (2.4)
 Improve regulatory system 1 (3.1) 6 (18.8) 14 (53.1) 11 (34.4)   32 (11.1)
 Improving supply chain   1 (6.7) 7 (46.7) 7 (46.7)   15 (5.2)
 Laboratory supplies and training   6 (15.4) 27 (69.2) 6 (15.4)   39 (13.5)
 Operations research 2 (66.7)   1 (33.3)    3 (1.0)
 Surveillance 3 (8.3) 10 (27.8) 21 (58.3) 2 (5.6)   36 (12.5)
 Training/capacity building   1 (9.1) 6 (54.5) 4 (36.4)   11 (3.8)
 Pharmacovigilance NOS 2 (6.3) 1 (3.1) 23 (71.9) 6 (18.8)   32 (11.1)
 Pharmacovigilance NOS-unfunded    26 (100)    26 (9.0)
 Surveillance-not funded 5 (100)      5 (1.7)
 Context onlya      39 (100) 39 (13.5)
 Historical activityb   12 (17.4) 37 (53.6) 17 (24.6) 3 (4.4) 69 (24.0)
 Total 14 (4.9) 40 (13.9) 154 (53.5) 49 (17.0) 42 (14.6)  
  1. aExcerpts that described pharmacovigilance activities occurring within the country but that were not supported or funded by the current or past grants
  2. bExcerpts that described pharmacovigilance activities that were previously funded by the grant making organization but were not being supported in the current grant